ARKO Corp
For the period ended Jun 30, 2024. Filed Aug 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 6, 2024
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-03-31; filed 2024-05-07.
0000950170-24-054447
Item 1A. Risk FactorsUnregistered Sales of Equity Securities, and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2024-06-30; filed 2024-08-06.
0000950170-24-091732
Item 1A. Risk FactorsUnregistered Sales of Equity Securities, and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 12 previous paragraphs and 9 current paragraphs.
8 unchanged; 0 reworded; 1 added; 4 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
1 We repurchased these shares of our common stock in connection with the net settlement of shares issued as a result of the vesting of restricted stock units and performance-based restricted stock units.
Removed paragraphs (4)
Previous report
In addition to the shares of common stock we purchased under our publicly announced $100 million share repurchase program, we repurchased 118 thousand shares of our common stock at an aggregate cost of $1.0 million, or an average purchase price of $8.35 per share, in connection with the net settlement of shares issued as a result of the vesting of restricted stock units.
Previous report
In addition to the shares of common stock we purchased under our publicly announced $100 million share repurchase program, we repurchased 220 thousand shares of our common stock at an aggregate cost of $1.8 million, or an average purchase price of $8.00 per share, in connection with the net settlement of shares issued as a result of the vesting of performance based restricted stock units.
Previous report
We repurchased 3.4 million shares of our common stock at a cost of $19.3 million, or a purchase price of $5.66 per share, in connection with the settlement of deferred consideration pursuant to the TEG Purchase Agreement Amendment, under our publicly announced $100 million share repurchase program. In addition to the shares of common stock we repurchased, we repurchased 125 thousand shares of our common stock at an aggregate cost of $0.8 million, or an average purchase price of $6.48 per share, in connection with the net settlement of shares issued as a result of the vesting of restricted stock units.
Previous report
Except as noted in footnotes 1, 2 and 3 above with respect to shares repurchased in connection with the vesting of restricted stock units, all of the above repurchases were made on the open market at prevailing market prices plus related expenses under our share repurchase program, which authorizes the repurchase of up to $100 million of our common stock. We publicly announced this program on February 23, 2022 and announced the increased amount authorized to be repurchased on May 16, 2023. In May 2024, we increased the size of our share repurchase program for up to an aggregate of $125.0 million of our outstanding shares of common stock.